Q4 2023 Holdings
Filed 2024-02-09 | 16 holdings | $839.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Kymera Therapeutics, Inc.(KYMR) | Common Stock | 501575104 | $149.2M | 5,858,262 | 17.8% |
| Disc Medicine, Inc.(IRON) | Common Stock | 254604101 | $147.6M | 2,555,172 | 17.6% |
| Dyne Therapeutics, Inc.(DYN) | Common Stock | 26818M108 | $131.5M | 9,885,449 | 15.7% |
| Third Harmonic Bio, Inc.(THRD) | Common Stock | 88427A107 | $119.7M | 10,907,859 | 14.2% |
| Day One Biopharmaceuticals, Inc.(DAWN) | Common Stock | 23954D109 | $111.1M | 7,608,394 | 13.2% |
| Korro Bio, Inc.(KRRO) | Common Stock | 500946108 | $53.6M | 1,119,292 | 6.4% |
| Aerovate Therapeutics, Inc. | Common Stock | 008064107 | $46.1M | 2,039,249 | 5.5% |
| Vigil Neuroscience, Inc.(VIGL) | Common Stock | 92673K108 | $19.7M | 5,836,874 | 2.3% |
| Replimune Group, Inc.(REPL) | Common Stock | 76029N106 | $17.7M | 2,098,300 | 2.1% |
| Generation Bio, Co.(GBIOGBX) | Common Stock | 37148K100 | $13.7M | 8,279,484 | 1.6% |
| Ikena Oncology, Inc. | Common Stock | 45175G108 | $9.9M | 5,018,178 | 1.2% |
| Akero Therapeutics, Inc.(AKRO) | Common Stock | 00973Y108 | $8.4M | 359,251 | 1.0% |
| AvroBio, Inc. | Common Stock | 05455M100 | $6.2M | 4,541,381 | 0.7% |
| Dianthus Therapeutics, Inc.(DNTH) | Common Stock | 252828108 | $2.5M | 236,979 | 0.3% |
| Xilio Therapeutics, Inc.(XLO) | Common Stock | 98422T100 | $1.5M | 2,759,344 | 0.2% |
| Spero Therapeutics, Inc.(SPRO) | Common Stock | 84833T103 | $1.5M | 1,013,438 | 0.2% |